Literature DB >> 35547012

Therapeutic effects of CoenzymeQ10, Biochanin A and Phloretin against arsenic and chromium induced oxidative stress in mouse (Mus musculus) brain.

Swapnil Tripathi1, Shabrin Fhatima1, Dharati Parmar1, Dhirendra Pratap Singh1, SukhDev Mishra2, Rajeev Mishra3, Gyanendra Singh1.   

Abstract

Arsenic and chromium are the most common environmental toxicants prevailing in nature. Hence, the present study endeavors to investigate the salutary effects of Coenzyme Q10 (CoQ10), Biochanin A (BCA), and Phloretin (PHL) on the combined neurotoxic impact of arsenic and chromium in the Swiss albino mice (Mus musculus). Sodium meta-arsenite (100 ppm) and potassium dichromate (75 ppm) were given orally in conjugation with CoQ10 (10 mg/kg), BCA & PHL (50 mg/kg each) in accordance with body weight per day for the 2 weeks experimental duration. Weight reduction was figured out in the exposed toxic group of arsenic and chromium in contrast with the comparison group (control), and with the selected anti-oxidants treatment, it rose significantly to the basal status (p < 0.05). The concentration of arsenic and chromium was reduced significantly (p < 0.001) amidst all the natural compounds co-medicated groups. Anti-oxidant indicators, viz. lipid peroxidation (LPO) and protein carbonyl content (PCC), were found elevated, with reduction observed in the levels of superoxide dismutase (SOD), reduced glutathione (GSH), glutathione s-transferase (GST), and total thiols (TT) in the arsenic and chromium, co-exposed mice. The alterations in redox homeostasis were well corroborated with the estimations of cholinesterase's enzymes (p < 0.05) along with DNA fragmentation assay and altered Nrf2 signaling. The administration of CoQ10, BCA, and PHL ameliorated the effects of arsenic and chromium induced oxidative stress in the exposed mice. Our research unfolds the remedial outcome of these natural compounds contrary to the combined arsenic and chromium associated-neurotoxicity in the experimental model. © King Abdulaziz City for Science and Technology 2022.

Entities:  

Keywords:  Antioxidants; Arsenic; Biochanin A; Chromium; Coenzyme Q10; Natural compounds; Nrf2; Oxidative stress; Phloretin

Year:  2022        PMID: 35547012      PMCID: PMC9023648          DOI: 10.1007/s13205-022-03171-w

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.893


  60 in total

1.  Tissue sulfhydryl groups.

Authors:  G L ELLMAN
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

Review 2.  Nitric oxide as a retrograde messenger during long-term potentiation in hippocampus.

Authors:  R D Hawkins; H Son; O Arancio
Journal:  Prog Brain Res       Date:  1998       Impact factor: 2.453

Review 3.  Arsenic-induced oxidative stress and its reversibility.

Authors:  Swaran J S Flora
Journal:  Free Radic Biol Med       Date:  2011-04-13       Impact factor: 7.376

4.  Caffeic acid phenethyl ester protects the brain against hexavalent chromium toxicity by enhancing endogenous antioxidants and modulating the JAK/STAT signaling pathway.

Authors:  Ayman M Mahmoud; Sanaa M Abd El-Twab
Journal:  Biomed Pharmacother       Date:  2017-05-02       Impact factor: 6.529

5.  Chromium oxide nanoparticle-induced biochemical and histopathological alterations in the kidneys and brain of Wistar rats.

Authors:  Ravish Fatima; Kafil Akhtar; M Mobarak Hossain; Riaz Ahmad
Journal:  Toxicol Ind Health       Date:  2017-10-25       Impact factor: 2.273

6.  The hypothetical roles of arsenic in multiple sclerosis by induction of inflammation and aggregation of tau protein: A commentary.

Authors:  Mohammadreza Alizadeh-Ghodsi; Ali Zavvari; Abbas Ebrahimi-Kalan; Mohammad Reza Shiri-Shahsavar; Bahman Yousefi
Journal:  Nutr Neurosci       Date:  2016-10-04       Impact factor: 4.994

7.  Toxic effects of perinatal arsenic exposure on the brain of developing rats and the beneficial role of natural antioxidants.

Authors:  Amparo Herrera; Javier Pineda; María Teresa Antonio
Journal:  Environ Toxicol Pharmacol       Date:  2013-04-01       Impact factor: 4.860

8.  Acetyl- and butyrylcholinesterase activity in the cerebrospinal fluid of patients with Parkinson's disease.

Authors:  J Sirviö; H S Soininen; R Kutvonen; J M Hyttinen; E L Helkala; P J Riekkinen
Journal:  J Neurol Sci       Date:  1987-11       Impact factor: 3.181

9.  Arsenic-induced oxidative stress, cholinesterase activity in the brain of Swiss albino mice, and its amelioration by antioxidants Vitamin E and Coenzyme Q10.

Authors:  Anupama Sharma; Chaoba Kshetrimayum; Harsiddha G Sadhu; Sunil Kumar
Journal:  Environ Sci Pollut Res Int       Date:  2018-06-08       Impact factor: 4.223

10.  Medicinal plants and natural products in amelioration of arsenic toxicity: a short review.

Authors:  Sanjib Bhattacharya
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.